Recent Quarter Total Invested
$400.97 M
Recent Quarter Institutional Ownership Percentage
120.84%
Total Invested of Last Quarter
$902.90 M
Ownership Percentage of Last Quarter
121.68%
Fate Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| REDMILE GROUP, LLC | 08/14/2024 | 13.17 M | $43.19 M | 0.00% | 13.03% |
| VANGUARD GROUP INC | 08/13/2024 | 10.57 M | $34.67 M | 6.65% | 10.45% |
| BLACKROCK INC. | 08/13/2024 | 10.12 M | $33.18 M | 11.17% | 10.01% |
| BOXER CAPITAL, LLC | 08/14/2024 | 8.22 M | $26.95 M | 0.00% | 8.13% |
| DEEP TRACK CAPITAL, LP | 08/14/2024 | 5.57 M | $18.28 M | 0.00% | 5.51% |
| STATE STREET CORP | 08/14/2024 | 5.34 M | $17.51 M | -33.57% | 5.28% |
| BELLEVUE GROUP AG | 08/14/2024 | 4.84 M | $15.87 M | 0.00% | 4.79% |
| CITADEL ADVISORS LLC | 08/14/2024 | 4.49 M | $14.72 M | 43.32% | 4.44% |
| D. E. SHAW & CO., INC. | 08/14/2024 | 4.08 M | $13.38 M | 49.32% | 4.03% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 08/14/2024 | 3.56 M | $11.66 M | 62.34% | 3.52% |
| JOHNSON & JOHNSON | 08/09/2024 | 3.38 M | $11.08 M | 0.00% | 3.34% |
| MORGAN STANLEY | 08/14/2024 | 3.15 M | $10.33 M | 2.68% | 3.11% |
| BAKER BROS. ADVISORS LP | 08/14/2024 | 3.00 M | $9.83 M | 64.88% | 2.97% |
| ASSENAGON ASSET MANAGEMENT S.A. | 07/18/2024 | 2.57 M | $8.45 M | 1.04% | 2.55% |
| GOLDMAN SACHS GROUP INC | 08/13/2024 | 2.35 M | $7.70 M | 16.71% | 2.32% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/09/2024 | 2.25 M | $7.37 M | 17.91% | 2.22% |
| DIMENSIONAL FUND ADVISORS LP | 08/09/2024 | 2.13 M | $6.99 M | 100.37% | 2.11% |
| ACADIAN ASSET MANAGEMENT LLC | 08/06/2024 | 2.01 M | $6.59 M | 17.19% | 1.99% |
| VESTAL POINT CAPITAL, LP | 08/14/2024 | 2.00 M | $6.56 M | 150.00% | 1.98% |
| BANK OF AMERICA CORP /DE/ | 08/14/2024 | 1.99 M | $6.51 M | 3.44% | 1.96% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 08/14/2024 | 1.69 M | $5.56 M | -15.28% | 1.68% |
| JPMORGAN CHASE & CO | 08/12/2024 | 1.55 M | $5.10 M | -11.66% | 1.54% |
| TWO SIGMA ADVISERS, LP | 08/14/2024 | 1.52 M | $5.00 M | 5.97% | 1.51% |
| ORBIMED ADVISORS LLC | 08/14/2024 | 1.36 M | $4.45 M | 0.00% | 1.34% |
| ARTAL GROUP S.A. | 08/14/2024 | 1.03 M | $3.39 M | 186.56% | 1.02% |
| FEDERATED HERMES, INC. | 08/08/2024 | 1.03 M | $3.38 M | 2.40% | 1.02% |
| TWO SIGMA INVESTMENTS, LP | 08/14/2024 | 1.02 M | $3.35 M | 284.90% | 1.01% |
| WOODLINE PARTNERS LP | 08/14/2024 | 1.00 M | $3.29 M | -47.04% | 0.99% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/12/2024 | 879,375 | $2.88 M | -8.05% | 0.87% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 08/14/2024 | 870,000 | $2.85 M | -59.35% | 0.86% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 08/14/2024 | 870,000 | $2.85 M | 0.00% | 0.86% |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 08/14/2024 | 850,000 | $2.79 M | 325.00% | 0.84% |
| NORTHERN TRUST CORP | 08/14/2024 | 736,674 | $2.42 M | 2.88% | 0.73% |
| TANG CAPITAL MANAGEMENT LLC | 08/14/2024 | 700,000 | $2.30 M | 0.00% | 0.69% |
| RENAISSANCE TECHNOLOGIES LLC | 08/09/2024 | 548,544 | $1.80 M | 100.00% | 0.54% |
| OCTAGON CAPITAL ADVISORS LP | 08/14/2024 | 520,800 | $1.71 M | 0.00% | 0.52% |
| SUPERSTRING CAPITAL MANAGEMENT LP | 08/14/2024 | 497,360 | $1.63 M | -45.97% | 0.49% |
| GCM GROSVENOR HOLDINGS, LLC | 08/14/2024 | 495,916 | $1.63 M | 0.00% | 0.49% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2024 | 446,668 | $1.47 M | 100.00% | 0.44% |
| BANK OF NEW YORK MELLON CORP | 07/25/2024 | 374,132 | $1.23 M | 23.89% | 0.37% |
| PRUDENTIAL FINANCIAL INC | 08/13/2024 | 356,101 | $1.17 M | -7.07% | 0.35% |
| E FUND MANAGEMENT CO., LTD. | 08/12/2024 | 355,225 | $1.17 M | 930.23% | 0.35% |
| PERCEPTIVE ADVISORS LLC | 08/16/2024 | 345,575 | $1.13 M | 100.00% | 0.34% |
| MARSHALL WACE, LLP | 08/14/2024 | 330,082 | $1.08 M | -4.45% | 0.33% |
| CAMPBELL & CO INVESTMENT ADVISER LLC | 08/13/2024 | 324,585 | $1.06 M | 100.00% | 0.32% |
| NUVEEN ASSET MANAGEMENT, LLC | 08/09/2024 | 324,004 | $1.06 M | 8.13% | 0.32% |
| BRUCE & CO., INC. | 08/09/2024 | 300,000 | $984,000 | 109.79% | 0.30% |
| MONACO ASSET MANAGEMENT SAM | 08/07/2024 | 286,900 | $941,032 | -9.44% | 0.28% |
| GSA CAPITAL PARTNERS LLP | 08/15/2024 | 264,467 | $867,000 | 405.88% | 0.26% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 08/15/2024 | 262,414 | $860,718 | 73.65% | 0.26% |
Fate Therapeutics, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of FATE shares?
During the previous two years, 257 institutional investors and hedge funds held shares of Fate Therapeutics, Inc.. The most heavily invested institutionals were:
Redmile Group, LLC: 13.17 M
VANGUARD GROUP INC: 10.57 M
BlackRock Inc.: 10.12 M
Boxer Capital, LLC: 8.22 M
Deep Track Capital, LP: 5.57 M
STATE STREET CORP: 5.34 M
-
What percentage of Fate Therapeutics, Inc. stock is owned by institutional investors?
120.84% of Fate Therapeutics, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at FATE ?
Institutional investors have bought a total of 130.82 M shares in the last 24 months. This purchase volume represents approximately $457.88 M in transactions.